SCHEMBL6987902

SCHEMBL6987902

CCOC(=O)CCc1ccc(F)c(NC(=O)C(F)(F)F)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 2/20 0.48
CYP4A11 Q02928 2/20 0.48
RAB9A P51151 2/20 0.43
EPHX2 P34913 1/20 0.43
CYP4Z1 Q86W10 1/20 0.43
PDE3B Q13370 1/20 0.42
PDE3A Q14432 1/20 0.42
P2RY12 Q9H244 1/20 0.42
SYK P43405 3/20 0.40
HDAC4 P56524 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
ALDH1A1 P00352 1/20 0.39
GAA P10253 1/20 0.39
THRB P10828 1/20 0.39
HTT P42858 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
NPC1 O15118 1/20 0.38
MAPT P10636 1/20 0.38
PKM P14618 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18455274 0.86 RAB9A (0.49) CYP4F2CYP4A11RAB9AEPHX2CYP4Z1
SCHEMBL18455644 0.80 CYP4F2 (0.41) CYP4F2CYP4A11RAB9AEPHX2CYP4Z1
SCHEMBL1816399 0.79 SYK (0.52) CYP4F2CYP4A11EPHX2SYKHDAC4
SCHEMBL6913578 0.79 CYP4F2 (0.61) CYP4F2CYP4A11EPHX2CYP4Z1PDE3B
SCHEMBL8364365 0.77 CYP4F2 (0.59) CYP4F2CYP4A11EPHX2CYP4Z1PDE3B
SCHEMBL6985238 0.76 CYP4F2 (0.58) CYP4F2CYP4A11RAB9AEPHX2CYP4Z1
SCHEMBL6988369 0.76 CYP4F2 (0.43) CYP4F2CYP4A11RAB9AALDH1A1GAA
SCHEMBL6983810 0.76 TTR (0.53) RAB9AP2RY12HTTNPC1APP
SCHEMBL6983807 0.76 TTR (0.53) RAB9AP2RY12HTTNPC1APP
SCHEMBL901787 0.75 CYP4F2 (0.56) CYP4F2CYP4A11CYP4Z1PDE3BPDE3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030078251-A1 Benzoxazepinones and their use as squalene synthase inhibitors TAKEDA CHEMICAL INDUSTRIES LTD. (JP) 2003-04-24 US disclosed
EP-1292585-A1 BENZOXAZEPINONES AND THEIR USE AS SQUALENE SYNTHASE INHIBITORS Takeda Chemical Industries, Ltd. (JP) 2003-03-19 EP disclosed
WO-2001098282-A1 BENZOXAZEPINONES AND THEIR USE AS SQUALENE SYNTHASE INHIBITORS TAKEDA CHEMICAL INDUSTRIES, LTD (JP) 2001-12-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030078251-A1 Benzoxazepinones and their use as squalene synthase inhibitors SQLE, CYP17A1, ACOX1 CYP4F2 760/4885CYP4A11 71/4885RAB9A 3825/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.